-
NSC-23766: Translating Rac1 Biology
2026-09-10
A thought-leadership guide to using NSC-23766 trihydrochloride as a mechanistic Rac1 probe, connecting GEF-dependent signaling with breast cancer, endothelial barrier biology, stem cell mobilization, and emerging metabolic insights.
-
Ionomycin Free Acid for Calcium–FAK Studies
2026-09-10
Ionomycin free acid enables controlled calcium ion transport for linking rapid intracellular calcium increase to delayed FAK stability, adhesion, and proteolysis assays. This workflow distinguishes a calcium perturbation tool from a direct FAK inhibitor while extending the FAISL–FAK findings into testable, hypothesis-driven experiments.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-09
RIPA Lysis Buffer (Medium) supports reproducible protein extraction from cultured cells and tissues in extracellular-vesicle cancer studies. Its balanced detergent system and built-in inhibitor set make it practical for Western blotting, pathway validation, and carefully optimized immunoprecipitation workflows.
-
Fungal IAA, DOPE, and Rice Blast Conidial Death
2026-09-09
A 2026 Molecular Plant Pathology study shows that fungus-derived indole-3-acetic acid (IAA) promotes developmental conidial death in Magnaporthe oryzae by connecting lipid metabolism, iron accumulation, lipid peroxidation, and autophagy. Genetic mutants and phosphatidylethanolamine rescue experiments place IAA and PPOA in a pathway that supports ferroptotic death, appressorium formation, and rice blast pathogenicity.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-09-08
Dimethyloxalylglycine (DMOG), SKU A4506, provides a cell-permeable way to investigate pharmacologic hypoxia-inducible factor stabilization and related oxygen-sensing workflows. It is intended for controlled scientific research, including in vitro hypoxia and inflammation studies, and should not be used for diagnostic, clinical, or therapeutic applications.
-
mTORC1 Oscillation Across the Cell Cycle
2026-09-08
The reference study shows that mTORC1 activity is not constant during proliferation: it is lowest in mitosis and G1 and highest during S and G2. This phase-specific pattern supports interphase progression, helps cells satisfy the Chk1/Wee1-dependent G2/M checkpoint, and creates distinct sensitivities to autophagy induction.
-
Temafloxacin: Applied Antibacterial Research Workflows
2026-09-07
Temafloxacin supports practical MIC, time-kill, respiratory, atypical-pathogen, and intracellular infection workflows through dual targeting of bacterial DNA gyrase and topoisomerase IV. This guide connects concentration-controlled bench assays with pharmacokinetic context, troubleshooting, and exposure-aware experimental design.
-
From Mouse Genotype to Macrophage Mechanism
2026-09-07
Translational conclusions are only as strong as the mouse models behind them. This thought-leadership article connects rapid, purification-free genotyping with new evidence that macrophage identity can shift during liver metastasis, offering a strategic framework for model validation, lineage-tracing studies, and reproducible translational research.
-
Dihydrotestosterone Workflows for AR Signaling
2026-09-05
Dihydrotestosterone (DHT) provides a controlled way to activate androgen receptor signaling and interrogate EGFR, ERBB2, AKT, and ERK responses in bladder cancer models. This practical guide also distinguishes established cancer and ALS applications from exploratory extensions into germ-cell assays, with formulation, workflow, and troubleshooting guidance.
-
Podocyte Exosomal HMGB1 in Lupus Nephritis
2026-09-04
The reference study identifies podocyte-derived exosomal HMGB1 as a mediator of glomerular endothelial cell injury in lupus nephritis and places TRIM27 downstream of this intercellular signal. Its combined human, cellular, pharmacologic, and mouse-model evidence provides a framework for testing whether vesicle-mediated podocyte–endothelial communication contributes to proteinuria and renal inflammation.
-
Cdc42-Targeted Signaling in Kidney Fibrosis
2026-09-04
The reference study identifies the plant-derived daphnepedunin A as an anti-fibrotic lead that acts through Cdc42-mediated control of the PKCζ/GSK-3β/β-catenin axis. Its combination of bioassay-guided chemistry, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a useful framework for evaluating Cdc42 as a kidney-fibrosis target.
-
NSC-23766: Translational Control of Rac1
2026-09-03
NSC-23766 offers a mechanistically defined way to interrogate Rac1 activation across cancer, endothelial, intestinal, and stem-cell models. This thought-leadership article connects GEF-level pharmacology with assay strategy, translational biomarker selection, and the emerging biology of Rac-regulated phagocytosis.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-03
TH287 gives cancer researchers a precise way to stress oxidized nucleotide handling before ionizing radiation, with schedule optimization at the center of the workflow. This article translates CRPC findings into practical dosing, DNA-damage assays, troubleshooting steps, and selectivity controls.
-
Cdc42 Targeting in Kidney Fibrosis: Study Insights
2026-09-02
The reference study identifies the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42 and interrupts downstream PKCζ/GSK-3β/β-catenin signaling. Its combination of bioassay-guided discovery, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42-directed strategies in chronic kidney disease.
-
Substance P Workflows for NK-1 Signaling Research
2026-09-02
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with a water-compatible peptide workflow. Learn how spectral preprocessing concepts from bioaerosol research can strengthen assay quality control without overstating cross-domain evidence.